LAG3 and neoplasm: Studies have shown that human CD8 + T cells often express KIRs and NKG2 A in a mutually exclusive manner, and the absence of PD-1 and LAG3 allows NKG2 A to impede the anti-tumor immunity of CD8 + T cells [30, 31].